| Mrs Kathryn Marie Landherr, MD | |
|
12200 Renfert Way Ste 100, Austin, TX 78758-5654 | |
| (512) 451-8211 | |
| (512) 495-4095 |
| Full Name | Mrs Kathryn Marie Landherr |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 27 Years |
| Location | 12200 Renfert Way Ste 100, Austin, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144203431 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | P6206 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aa Obgyn Pllc | 6103079462 | 12 |
News Archive
Obesity may put African-Americans who have survived one stroke at risk for a second stroke by increasing their risk of hypertension (high blood pressure), diabetes and high cholesterol, according to an article in the March issue of Archives of Neurology, one of the JAMA/Archives journals.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced its entry into the Integrated Optical Biosensor System (IOBS) market. IOBS are a relatively new classification of pathogen detection equipment which use advanced fiber optic-based technology to detect a wide variety of human and animal pathogens.
Inovio Pharmaceuticals, Inc. announced today that its SynCon avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines.
Reata Pharmaceuticals, Inc. (Reata) and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) announced today that they have entered into a licensing agreement that provides Kyowa Hakko Kirin with the exclusive rights to develop and commercialize Reata's lead compound, bardoxolone methyl (bardoxolone), in Japan and other selected Asian markets.
Meda has signed a long-term license agreement with the specialty division of Mylan Inc., Dey Pharma, L.P., for exclusive marketing and distribution rights of EpiPen® (epinephrine) Auto-Injector in Europe. EpiPen is used for emergency treatment of severe allergic reactions (anaphylaxis). Anaphylaxis can occur quickly (often within a couple of minutes) and may be life-threatening.
› Verified 4 days ago
| Entity Name | Aa Obgyn Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104170901 PECOS PAC ID: 6103079462 Enrollment ID: O20130117000089 |
News Archive
Obesity may put African-Americans who have survived one stroke at risk for a second stroke by increasing their risk of hypertension (high blood pressure), diabetes and high cholesterol, according to an article in the March issue of Archives of Neurology, one of the JAMA/Archives journals.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced its entry into the Integrated Optical Biosensor System (IOBS) market. IOBS are a relatively new classification of pathogen detection equipment which use advanced fiber optic-based technology to detect a wide variety of human and animal pathogens.
Inovio Pharmaceuticals, Inc. announced today that its SynCon avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines.
Reata Pharmaceuticals, Inc. (Reata) and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) announced today that they have entered into a licensing agreement that provides Kyowa Hakko Kirin with the exclusive rights to develop and commercialize Reata's lead compound, bardoxolone methyl (bardoxolone), in Japan and other selected Asian markets.
Meda has signed a long-term license agreement with the specialty division of Mylan Inc., Dey Pharma, L.P., for exclusive marketing and distribution rights of EpiPen® (epinephrine) Auto-Injector in Europe. EpiPen is used for emergency treatment of severe allergic reactions (anaphylaxis). Anaphylaxis can occur quickly (often within a couple of minutes) and may be life-threatening.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kathryn Marie Landherr, MD 12200 Renfert Way, Suite 100, Austin, TX 78758-5654 Ph: (512) 451-8211 | Mrs Kathryn Marie Landherr, MD 12200 Renfert Way Ste 100, Austin, TX 78758-5654 Ph: (512) 451-8211 |
News Archive
Obesity may put African-Americans who have survived one stroke at risk for a second stroke by increasing their risk of hypertension (high blood pressure), diabetes and high cholesterol, according to an article in the March issue of Archives of Neurology, one of the JAMA/Archives journals.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced its entry into the Integrated Optical Biosensor System (IOBS) market. IOBS are a relatively new classification of pathogen detection equipment which use advanced fiber optic-based technology to detect a wide variety of human and animal pathogens.
Inovio Pharmaceuticals, Inc. announced today that its SynCon avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines.
Reata Pharmaceuticals, Inc. (Reata) and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) announced today that they have entered into a licensing agreement that provides Kyowa Hakko Kirin with the exclusive rights to develop and commercialize Reata's lead compound, bardoxolone methyl (bardoxolone), in Japan and other selected Asian markets.
Meda has signed a long-term license agreement with the specialty division of Mylan Inc., Dey Pharma, L.P., for exclusive marketing and distribution rights of EpiPen® (epinephrine) Auto-Injector in Europe. EpiPen is used for emergency treatment of severe allergic reactions (anaphylaxis). Anaphylaxis can occur quickly (often within a couple of minutes) and may be life-threatening.
› Verified 4 days ago
Dr. Chris C Hart, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9805 Brodie Ln, Austin, TX 78748 Phone: 512-462-1936 Fax: 512-394-9388 | |
Dr. Robert C Johnston, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 12200 Renfert Way Ste G-3, Austin, TX 78758 Phone: 512-821-2540 Fax: 512-973-3533 | |
Dr. Keikhosrow M Kavoussi, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4303 James Casey St, Suite A, Austin, TX 78745 Phone: 512-444-1414 Fax: 512-444-5621 | |
Dr. Andrea L. Campaigne, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12201 Renfert Way Ste 250, Austin, TX 78758 Phone: 512-994-2662 Fax: 512-406-6202 | |
Jonathan Edmond Pepper, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6611 River Place Blvd Ste 202, Austin, TX 78730 Phone: 512-473-8300 | |
Akua Tiwaa Afriyie-gray, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1301 Barbara Jordan Blvd Ste 303, Austin, TX 78723 Phone: 512-324-0970 | |
Mr. Sasan Askari, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4007 James Casey St, Suite A-250, Austin, TX 78745 Phone: 512-444-2111 Fax: 512-444-2114 |